- Universität Wien, Institut Anorganische Chemie
- Closing Date
The applicants should hold a Diploma or MSc degree in (molecular) biology, (bio-) chemistry, pharmacy or related life science disciplines. Accomplishment of a research project dealing with the development and preclinical evaluation of metal-based prodrugs of systemic cancer therapies including cancer-targeted and immunomodulatory compounds. Aim is the development of highly active cancer therapies with low adverse effects. Experience in cell culture techniques and animal models as well as molecular and cell biological analyses is an asset.
- Main contact
- Name: Elfriede Limberger